Roche Venture Fund Investor

Roche has been investing in early stage companies as part of collaborations since the early-1990s and independent of collaborations since 2002. All equity investments made by Roche in biotech and diagnostics companies (including collaboration investments) are negotiated and managed by the Roche Venture Fund. In the past 20 years, the Roche Venture Fund has invested in over 60 companies globally. Currently, Roche Venture Fund has a portfolio of around 30 companies located in 10 countries across Europe, North America and the Pacific Region. The fund is an evergreen fund with CHF 500 million available of which approximately 40% is currently invested.
Technology: Generate Novel Drug Candidates
Industry: Drug Discovery
Headquarters: Basel, Basel-Stadt, Switzerland
Founded Date: 2001
Employees Number: Undisclosed
Funding Status: N/A
Investor Type: Corporate Venture Capital
Investment Stage: Undisclosed
Number Of Exits: 20

Visit Website
Register and Claim Ownership